Excella develops and manufactures active pharmaceutical ingredients and medicines according to the highest international standards. It specializes in the production of high-potent substances for cancer therapy and immunosuppression.

Excella

Excella GmbH | 154 followers on LinkedIn. 

Stability manager bei EXCELLA / FAREVA

Eck Peter

Controller bei Excella GmbH & Co KG

Michael Schrödel

Stellvertretende Herstellleitung

Christine Lang

Project manager bei Excella GmbH

Georg Straller

Excella GmbH

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Nov 13, 2024 8:34 AM	e901673b
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Nov 13, 2024 8:34 AM	0ea6d6c8
crunchbase trigger	general	Nov 13, 2024 8:34 AM	3d173d78
crunchbase profile	general
li profile	general	Nov 13, 2024 8:34 AM	654365fd
translate crunchbase fundingrounds	general
peers	general	Nov 13, 2024 8:34 AM	243d1b47
news basic	general	Nov 13, 2024 8:34 AM	8455ce24
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

EXCE

DE:EXCELLA

Excella